Phathom Pharmaceuticals's market cap is currently $378.81M. The company's EPS TTM is $-5.693; its P/E ratio is ―; Phathom Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 682.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 515.00K	$ -620.00K	$ -521.00K	$ -300.00K	$ -8.00K
Operating Income	$ -167.31M	$ -172.44M	$ -135.08M	$ -125.67M	$ -106.22M
EBITDA	$ -159.05M	$ -171.82M	$ -134.56M	$ -124.19M	$ -250.95M
Net Income	$ -201.59M	$ -223.01M	$ -148.09M	$ -133.32M	$ -209.74M
Balance Sheet
Cash & Short-Term Investments	$ 381.39M	$ 155.38M	$ 183.26M	$ 287.50M	$ 243.76M
Total Assets	$ 413.84M	$ 164.81M	$ 189.43M	$ 295.11M	$ 257.18M
Total Debt	$ 139.03M	$ 97.07M	$ 91.34M	$ 49.02M	$ 23.57M
Net Debt	$ -242.36M	$ -58.31M	$ -91.92M	$ -238.48M	$ -220.19M
Total Liabilities	$ 486.60M	$ 239.62M	$ 117.28M	$ 100.84M	$ 29.22M
Stockholders' Equity	$ -72.76M	$ -74.81M	$ 72.16M	$ 194.27M	$ 227.96M
Cash Flow
Free Cash Flow	$ -139.21M	$ -147.57M	$ -148.94M	$ -70.73M	$ -61.76M
Operating Cash Flow	$ -137.58M	$ -146.53M	$ -148.62M	$ -69.69M	$ -36.51M
Investing Cash Flow	$ -1.63M	$ -1.04M	$ -328.00K	$ -1.04M	$ -25.25M
Financing Cash Flow	$ 367.58M	$ 120.04M	$ 44.71M	$ 114.46M	$ 304.65M

Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History

Income Statement >

Phathom Pharmaceuticals Debt to Assets

Balance Sheet >

Phathom Pharmaceuticals Cash Flow

Cash Flow >

Phathom Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing